圣诞节不良事件综合征:对世卫组织药监数据库的分析
Alex Hlavaty1, Matthieu Roustit2, Marc Manceau3
1University Grenoble-Alpes, Pharmacovigilance Unit, Grenoble-Alpes University Hospital, 38000 Grenoble, France.
药物不良事件,特别是精神和皮肤问题,在圣诞节期间增加. 这项研究强调了假期期间潜在的药物安全问题.
科学领域:
- 药物监督 药物监督 药物监督
- 药品安全 药品安全
- 季节性健康趋势
背景情况:
- 药物安全概况可以根据季节而波动.
- 圣诞节期间可能会对药物安全带来独特的挑战.
研究的目的:
- 评估和描述圣诞节期间药物安全概况的变化.
- 调查假期期间药物毒性是否加剧.
主要方法:
- 从世界卫生组织 (WHO) 药监数据库中对不良事件的回顾性分析 (2017年4月至2023年3月).
- 包括来自五个主要贡献国家的数据 (美国,法国,德国,意大利,英国).
- 分析了4,999,459个个案安全报告,重点关注圣诞节期间的影响 (12月至1月).
主要成果:
- 在圣诞节期间,独立于冬季的影响,报告的不良事件发生频率明显增加.
- 主要的不良事件包括精神疾病,感染和皮肤/皮下疾病.
- 与圣诞节期间不良事件增加相关的关键药物是氧化,阿达利穆马布和多塞塔克塞尔.
结论:
- 在圣诞节期间,药物不良事件,特别是精神病,传染病和皮肤病,更为常见.
- 这些发现强调了需要加强对假期期间药物安全的警.
更多相关视频
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
相关概念视频
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Regulation
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Clinical Trials
There are four phases in a clinical trial. A phase one...
